Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01325350 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 306
- Enrollment target
NCT01325350: Completed Phase 2 study, sponsored by Allergan.
NCT01325350 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 306 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (130% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01325350, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 306 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 2% solution in women with female pattern hair loss. All treatments will be provided in a double-blinded fashion except for minoxidil 2% solution which will be provided open-label.
Primary Outcome
TAHC was measured using digital imaging analysis and was reported in terminal hairs/centimeters squared (cm\^2). A positive change from Baseline indicated improvement (increase in the number of terminal hairs). A negative change from Baseline indicated worsening (decrease in the number of terminal hairs).
Interventions
- DRUG bimatoprost vehicle solution
- DRUG bimatoprost Formulation A
- DRUG bimatoprost Formulation B
- DRUG bimatoprost Formulation C
- DRUG minoxidil 2% solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
What the finished NCT01325350 record still lists
NCT01325350 is an interventional study that assigns participants to a tested intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (130% higher).
The record links to 0 conditions, and to 5 interventions - of which bimatoprost vehicle solution is the first listed.
NCT01325350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01325350 about?
NCT01325350 is a clinical study titled "Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss". This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 2% solution in women with female pattern hair loss. All treatments will be provided in a double-blinded fashion except for minoxidil 2% solution which will b...
What is the current status of trial NCT01325350?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 306 participants. The study started on 2011-06. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01325350?
The interventions under investigation include: bimatoprost vehicle solution (DRUG), bimatoprost Formulation A (DRUG), bimatoprost Formulation B (DRUG), bimatoprost Formulation C (DRUG), minoxidil 2% solution (DRUG).
Who is sponsoring clinical trial NCT01325350?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01325350's enrollment target sits among peer trials
306 165th of 2000 higher than 1,835 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia